FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149292297> ?p ?o ?g. }

• W2149292297 endingPage "3222" @default.
• W2149292297 startingPage "3216" @default.
• W2149292297 abstract "Annually influenza virus infections are responsible for hospitalization and mortality, especially in high risk groups. Constant antigenic changes in seasonal influenza viruses resulted from antigenic shifts and antigenic drifts, enable emerging of novel virus subtypes that may reduce current vaccine efficacy and impose the continuous revision of vaccine component. Currently available vaccines are usually limited by their production processes in terms of rapid adaptation to new circulating subtypes in high quantities meeting the global demand. Thus, new approaches to rapidly manufacture high yields of influenza vaccines are required. New technologies to reach maximal protection with minimal vaccine doses also need to be developed. In this study, we evaluated the systemic and local immunogenicity of a new double-adjuvanted influenza vaccine administered at the site of infection, the respiratory tract. This vaccine combines a plant-produced H1N1 influenza hemagglutinin antigen (HAC1), a silica nanoparticle-based (SiO2) drug delivery system and the mucosal adjuvant candidate bis-(3′,5′)-cyclic dimeric guanosine monophosphate (c-di-GMP). Mice were vaccinated by intratracheal route with HAC1/SiO2 or HAC1/c-di-GMP (single-adjuvanted vaccine) or HAC1/SiO2/c-di-GMP (double-adjuvanted vaccine) and evaluated for target-specific immune responses, such as hemagglutination inhibition and hemagglutinin-specific IgG titers, as well as local antibody (IgG and IgA) titers in the bronchoalveolar lavage (BAL). Furthermore, the HAC1-specific T-cell re-stimulation potential was assessed using precision-cut lung slices (PCLS) of vaccinated mice. The double-adjuvanted vaccine induced high systemic antibody responses comparable to the systemic vaccination control. In addition, it induced local IgG and IgA responses in the BAL. Furthermore, HAC1 induced a local T-cell response demonstrated by elevated IL-2 and IFN-γ levels in PCLS of c-di-GMP-vaccinated mice upon re-stimulation. Overall, the present study showed the potential of the double-adjuvanted vaccine to induce systemic humoral immune responses in intratracheally vaccinated mice. Furthermore, it induced a strong mucosal immune response, with evidence of antigen-primed T-cells in the lung." @default.
• W2149292297 created "2016-06-24" @default.
• W2149292297 creator A5003448027 @default.
• W2149292297 creator A5004244093 @default.
• W2149292297 creator A5005523386 @default.
• W2149292297 creator A5021552449 @default.
• W2149292297 creator A5022639213 @default.
• W2149292297 creator A5030498330 @default.
• W2149292297 creator A5044311719 @default.
• W2149292297 creator A5053801647 @default.
• W2149292297 creator A5084056836 @default.
• W2149292297 creator A5088052632 @default.
• W2149292297 date "2014-05-01" @default.
• W2149292297 modified "2023-10-16" @default.
• W2149292297 title "A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung" @default.
• W2149292297 cites W1502384597 @default.
• W2149292297 cites W1516009011 @default.
• W2149292297 cites W1625571551 @default.
• W2149292297 cites W1808739935 @default.
• W2149292297 cites W1965611801 @default.
• W2149292297 cites W1971718171 @default.
• W2149292297 cites W1974822286 @default.
• W2149292297 cites W2015245677 @default.
• W2149292297 cites W2016843175 @default.
• W2149292297 cites W2017103869 @default.
• W2149292297 cites W2020167375 @default.
• W2149292297 cites W2030865344 @default.
• W2149292297 cites W2034951867 @default.
• W2149292297 cites W2040038919 @default.
• W2149292297 cites W2042074731 @default.
• W2149292297 cites W2062821062 @default.
• W2149292297 cites W2066041237 @default.
• W2149292297 cites W2066639206 @default.
• W2149292297 cites W2067473360 @default.
• W2149292297 cites W2070281432 @default.
• W2149292297 cites W2082445383 @default.
• W2149292297 cites W2087668602 @default.
• W2149292297 cites W2091459248 @default.
• W2149292297 cites W2092292516 @default.
• W2149292297 cites W2095072719 @default.
• W2149292297 cites W2096306668 @default.
• W2149292297 cites W2102637384 @default.
• W2149292297 cites W2107587363 @default.
• W2149292297 cites W2124691528 @default.
• W2149292297 cites W2129402364 @default.
• W2149292297 cites W2161989681 @default.
• W2149292297 doi "https://doi.org/10.1016/j.vaccine.2014.04.011" @default.
• W2149292297 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24731807" @default.
• W2149292297 hasPublicationYear "2014" @default.
• W2149292297 type Work @default.
• W2149292297 sameAs 2149292297 @default.
• W2149292297 citedByCount "44" @default.
• W2149292297 countsByYear W21492922972014 @default.
• W2149292297 countsByYear W21492922972015 @default.
• W2149292297 countsByYear W21492922972016 @default.
• W2149292297 countsByYear W21492922972017 @default.
• W2149292297 countsByYear W21492922972018 @default.
• W2149292297 countsByYear W21492922972019 @default.
• W2149292297 countsByYear W21492922972020 @default.
• W2149292297 countsByYear W21492922972021 @default.
• W2149292297 countsByYear W21492922972022 @default.
• W2149292297 countsByYear W21492922972023 @default.
• W2149292297 crossrefType "journal-article" @default.
• W2149292297 hasAuthorship W2149292297A5003448027 @default.
• W2149292297 hasAuthorship W2149292297A5004244093 @default.
• W2149292297 hasAuthorship W2149292297A5005523386 @default.
• W2149292297 hasAuthorship W2149292297A5021552449 @default.
• W2149292297 hasAuthorship W2149292297A5022639213 @default.
• W2149292297 hasAuthorship W2149292297A5030498330 @default.
• W2149292297 hasAuthorship W2149292297A5044311719 @default.
• W2149292297 hasAuthorship W2149292297A5053801647 @default.
• W2149292297 hasAuthorship W2149292297A5084056836 @default.
• W2149292297 hasAuthorship W2149292297A5088052632 @default.
• W2149292297 hasBestOaLocation W21492922971 @default.
• W2149292297 hasConcept C147483822 @default.
• W2149292297 hasConcept C159047783 @default.
• W2149292297 hasConcept C159654299 @default.
• W2149292297 hasConcept C203014093 @default.
• W2149292297 hasConcept C22070199 @default.
• W2149292297 hasConcept C2777863537 @default.
• W2149292297 hasConcept C2778692840 @default.
• W2149292297 hasConcept C2780689484 @default.
• W2149292297 hasConcept C2780868878 @default.
• W2149292297 hasConcept C71924100 @default.
• W2149292297 hasConcept C86803240 @default.
• W2149292297 hasConcept C8891405 @default.
• W2149292297 hasConceptScore W2149292297C147483822 @default.
• W2149292297 hasConceptScore W2149292297C159047783 @default.
• W2149292297 hasConceptScore W2149292297C159654299 @default.
• W2149292297 hasConceptScore W2149292297C203014093 @default.
• W2149292297 hasConceptScore W2149292297C22070199 @default.
• W2149292297 hasConceptScore W2149292297C2777863537 @default.
• W2149292297 hasConceptScore W2149292297C2778692840 @default.
• W2149292297 hasConceptScore W2149292297C2780689484 @default.
• W2149292297 hasConceptScore W2149292297C2780868878 @default.
• W2149292297 hasConceptScore W2149292297C71924100 @default.
• W2149292297 hasConceptScore W2149292297C86803240 @default.
• W2149292297 hasConceptScore W2149292297C8891405 @default.

• next